Drug Free Solution (Drug Free Solution) EV-to-EBITDA : -0.01 (As of May. 16, 2024)

Drug Free Solution EV-to-EBITDA Chart

Drug Free Solution Quarterly Data
	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Feb14
EV-to-EBITDA	Get a 7-Day Free Trial						-30.52	-	-27.53	-33.52	-33.77

Competitive Comparison of Drug Free Solution's EV-to-EBITDA

For the Health Information Services subindustry, Drug Free Solution's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Drug Free Solution's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Drug Free Solution's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Drug Free Solution's EV-to-EBITDA falls into.

Drug Free Solution EV-to-EBITDA Calculation

Drug Free Solution's EV-to-EBITDA for today is calculated as:

Drug Free Solution's current Enterprise Value is $0.01 Mil.
Drug Free Solution's EBITDA for the trailing twelve months (TTM) ended in Feb. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drug Free Solution  (OTCPK:DSOL) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Drug Free Solution's PE Ratio for today is calculated as:

Drug Free Solution's share price for today is $0.0002.
Drug Free Solution's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.007.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Drug Free Solution EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Drug Free Solution's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Drug Free Solution (Drug Free Solution) Business Description